Search results for "Side effects"
Continue BP control, maintain benefits
Helping patients maintain normal blood pressure over the long haul pays off in cardiovascular and other health benefits, yet studies show that U.S. adults continue to backslide.
https://immattersacp.org/archives/2024/05/continue-bp-control-maintain-benefits.htm
1 May 2024
Lixisenatide linked with moderate symptom improvement in early Parkinson's
Patients with early Parkinson's disease in France who were treated with a glucagon-like peptide-1 receptor agonist had better outcomes on a motor disability scale at month 12 compared with those on placebo.
https://immattersacp.org/weekly/archives/2024/04/09/4.htm
9 Apr 2024
First NASH treatment, over-the-counter CGM approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/05/first-nash-treatment-over-the-counter-cgm-approved.htm
1 May 2024
ARBs appear to have fewer side effects, same effectiveness compared to ACE inhibitors
Researchers used large international databases to compare outcomes among patients who initiated hypertension therapy with angiotensin-converting enzyme (ACE) inhibitors versus angiotensin receptor blockers (ARBs) and concluded that ARBs should be preferred.
https://immattersacp.org/weekly/archives/2021/08/03/2.htm
3 Aug 2021
Multiple agents effective for excessive daytime sleepiness but may be discontinued due to side effects, review finds
A systematic review and meta-analysis of 14 trials found that solriamfetol, armodafinil-modafinil, and pitolisant were associated with reduced daytime sleepiness but also with headache, insomnia, and anxiety in patients with obstructive sleep apnea.
https://immattersacp.org/weekly/archives/2023/05/09/1.htm
9 May 2023
Be wary of benzodiazepines' side effects
Alternative strategies are increasingly recommended when managing conditions like insomnia and anxiety in elderly patients.
https://immattersacp.org/archives/2022/02/be-wary-of-benzodiazepines-side-effects.htm
1 Feb 2022
New 'weighs' to treat obesity
Even as the data on weight loss drugs mount, physicians need to help patients navigate potentially prohibitive costs and a continuing need for lifestyle change.
https://immattersacp.org/archives/2024/03/new-weighs-to-treat-obesity.htm
1 Mar 2024
Low-dose naltrexone not superior to placebo for fibromyalgia pain relief
While the drug showed a significant difference in improving memory problems in women with fibromyalgia, researchers warned that this might be a false positive and more research is needed.
https://immattersacp.org/weekly/archives/2023/12/12/2.htm
12 Dec 2023
Review offers guidance on selecting medications for COPD
Researchers suggest ways for clinicians to assess cognitive function, manual dexterity/strength, and peak inspiratory flow before choosing an inhaled medication delivery system for patients with chronic obstructive pulmonary disease (COPD).
https://immattersacp.org/weekly/archives/2023/11/21/4.htm
21 Nov 2023
Potential problematic prescribing in older women
Prescription of systemic estrogen therapy after menopause could be a red flag for use of other medications linked to dementia.
https://immattersacp.org/archives/2024/04/potential-problematic-prescribing-in-older-women.htm
1 Apr 2024